Concepedia

Author

Robert Mate

Bristol-Myers Squibb (United States)

Also Known As

Robert A Mate, Robert A. Mate, Robert Mate

13

Publications

421

Citations

9

H-Index

37

Concepts

All Affiliations

Bristol-Myers Squibb (United States)
RM

About

Robert Mate is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

350

2

Biochemistry

3

3

249

3

Natural Sciences

2

2

225

4

Microbiology

2

2

130

5

Social Sciences

1

1

13

Robert Mate

×

8

Publications

395

Citations

8

H-Index

YearCitations

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor

Kevin W. Gillman, John E. Starrett, Michael F. Parker,

ACS Medicinal Chemistry Letters

2010

183

Discovery of the first antibacterial small molecule inhibitors of MurB

Joanne J. Bronson, Kenneth DenBleyker, Paul Falk,

Bioorganic & Medicinal Chemistry Letters

2003

88

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials

Lawrence B. Snyder, Zhaoxing Meng, Robert Mate,

Bioorganic & Medicinal Chemistry Letters

2004

42

Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists

Ivar M. McDonald, Robert Mate, F. Christopher Zusi,

Bioorganic & Medicinal Chemistry Letters

2013

24

Design and Synthesis of a New Series of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

James A. Cook, F. Christopher Zusi, Ivar M. McDonald,

Journal of Medicinal Chemistry

2016

18

Design, Synthesis, and Structure–Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody–Drug Conjugates

Naidu S. Chowdari, Yong Zhang, Ivar M. McDonald,

Journal of Medicinal Chemistry

2020

15

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

Dalton King, Christiana Iwuagwu, Jim Cook,

ACS Medicinal Chemistry Letters

2017

13

Development of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists

Matthew D. Hill, Haiquan Fang, Dalton King,

ACS Medicinal Chemistry Letters

2016

12

Page 1